Special considerations in sinonasal tumors with orbitalinvolvement: our experience at Hospital Universitario SanIgnacio. Bogotá, Colombia

Main Article Content

María Camila Villegas Echeverri
Alfredo José Herrera Vivas
Juliana López Escobar
María Fernanda González Sánchez
Gabriel Sánchez de Guzmán

Abstract

Introduction: malignant sinonasal tumors (MSTs) represent an aggressive disea­se entity associated with poor prognosis and high mortality. The extent of orbital involvement and histological subtype significantly influence oncologic outcomes. However, controversy persists regarding the indication for orbital exenteration ver­sus orbital preservation. Objective: to describe the clinical and histopathological characteristics and oncologic outcomes, including overall survival, in patients with malignant sinonasal tumors with orbital invasion treated with either orbital preser­vation or orbital exenteration surgery at a high-complexity referral center in Bogotá, Colombia. Methods: a retrospective observational descriptive case series was con­ducted. Patients with histopathologically confirmed malignant sinonasal tumors with orbital involvement who underwent surgical treatment between January 2017 and December 2023 were included. Clinical and demographic variables, the degree of orbital invasion according to the Iannetti classification based on magnetic resonance imaging, histological subtype, type of surgical management, and adjuvant therapy were analyzed. Surgical decisions were made through a multidisciplinary head and neck tumor board. Overall survival was estimated using the Kaplan–Meier method. Results: thirteen patients were included; 54% presented with grade III orbital inva­sion. Seven distinct histopathological subtypes were identified. During follow-up, seven patients died due to tumor progression, six within the first postoperative year. The estimated overall survival was 30.7%, with a marked decline during the first 12 months, particularly among patients undergoing orbital exenteration with orbital apex involvement. Conclusion: malignant sinonasal tumors with orbital invasion are associated with low overall survival, especially in advanced stages. Therapeutic decision-making should be individualized through a multidisciplinary approach.

Article Details

Section

Trabajos Originales

How to Cite

1.
Special considerations in sinonasal tumors with orbitalinvolvement: our experience at Hospital Universitario SanIgnacio. Bogotá, Colombia. Acta otorrinolaringol cir cabeza cuello [Internet]. 2026 Feb. 9 [cited 2026 Feb. 10];53(4):317-28. Available from: https://mail.revista.acorl.org.co/index.php/acorl/article/view/822

References

1. Vartanian JG, Toledo RN, Bueno T, Kowalski LP. Orbital exenteration for sinonasal malignancies: indications, rehabilitation and oncologic outcomes. Curr Opin Otolaryngol Head Neck Surg. 2018;26(2):122-6. https://doi.org/10.1097/MOO.0000000000000441

2. Safi AF, Behn L, Rothamel D, Guntinas-Lichius O, Beutner D, Nickenig HJ, et al. Therapy of sinonasal malignancies invading the orbit-orbital exenteration versus preservation plus radiotherapy. J Craniomaxillofac Surg. 2017;45(2):258-61. https://doi.org/10.1016/j.jcms.2016.11.013

3. Li R, Tian S, Zhu Y, Zhu W, Wang S. Management of orbital invasion in sinonasal squamous cell carcinoma: 15 years’ experience. Int Forum Allergy Rhinol. 2020;10(2):243-55. https://doi.org/10.1002/alr.22465

4. Farber NI, Povolotskiy R, Bavier RD, Riccardi J, Eloy JA, Hsueh WD. Impact of palliative treatment on survival in sinonasal malignancies. Int Forum Allergy Rhinol. 2019;9(12):1499-507. https://doi.org/10.1002/alr.22432

5. Chu Y, Liu HG, Yu ZK. Patterns and incidence of sinonasal malignancy with orbital invasion. Chin Med J (Engl). 2012;125(9):1638-42.

6. Lisan Q, Kolb F, Temam S, Tao Y, Janot F, Moya-Plana A. Management of orbital invasion in sinonasal malignancies. Head Neck. 2016;38(11):1650-6. https://doi.org/10.1002/hed.24490

7. Ferrari M, Migliorati S, Tomasoni M, Crisafulli V, Nocivelli G, Paderno A, et al. Sinonasal cancer encroaching the orbit: Ablation or preservation? Oral Oncol. 2021;114:105185. https://doi.org/10.1016/j.oraloncology.2021.105185

8. Suárez C, Ferlito A, Lund VJ, Silver CE, Fagan JJ, Rodrigo JP, et al. Management of the orbit in malignant sinonasal tumors. Head Neck. 2008;30(2):242-50. https://doi.org/10.1002/hed.20736

9. Turri-Zanoni M, Lambertoni A, Margherini S, Giovannardi M, Ferrari M, Rampinelli V, et al. Multidisciplinary treatment algorithm for the management of sinonasal cancers with orbital invasion: A retrospective study. Head Neck. 2019;41(8):2777-88. https://doi.org/10.1002/hed.25759

10. Imola MJ, Schramm VL Jr. Orbital preservation in surgical management of sinonasal malignancy. Laryngoscope. 2002;112(8 Pt 1):1357-65. https://doi.org/10.1097/00005537-200208000-00007

11. Muscatello L, Fortunato S, Seccia V, Marchetti M, Lenzi R. The implications of orbital invasion in sinonasal tract malignancies. Orbit. 2016;35(5):278-84. https://doi.org/10.1080/01676830.2016.1193532

12. Gutiérrez Bayard L, Salas Buzón C, Román Rodríguez P. Estesioneuroblastoma: revisión de la literatura a propósito de dos casos. Oncología (Barc.). 2005;28(7):51-61.

Most read articles by the same author(s)